Contemporary results after repair of partial and transitional atrioventricular septal defects.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
03 2019
Historique:
received: 01 05 2018
revised: 28 09 2018
accepted: 12 10 2018
entrez: 14 5 2019
pubmed: 14 5 2019
medline: 25 2 2020
Statut: ppublish

Résumé

The exact incidence and risk factors for reoperation in partial and transitional atrioventricular septal defects are unclear. The goal of this study was to assess risk factors for left atrioventricular valve and left ventricular outflow tract reoperation in partial and transitional atrioventricular septal defects. All patients undergoing partial and transitional atrioventricular septal defects repair between 1995 and 2017 were reviewed. Patients were classified as infants (<1 year), toddlers (1-3 years), children (3-17 years), and adults (≥18 years). Survival and reoperation were assessed using log-rank test and Cox models for univariate and multivariable analyses, respectively. Overall, 265 patients underwent partial and transitional atrioventricular septal defects repair (partial: 177 [67%]). Median age was 2 years. The cohort included 73 infants (28%), 85 toddlers (32%), 94 children (35%), and 13 adults (5%). Trisomy 21 was present in 76 patients (29%), and in 216 patients (83%), the zone of apposition was completely closed. Perioperative mortality was 0.8%. Complete heart block did not develop in any patients. Ten-year survival and freedom from reoperation were 98% and 81%, respectively. On multivariable analysis, trisomy 21 (hazard ratio [HR], 0.16) and older age compared with infants (toddlers: HR, 0.35; children: HR, 0.25) were protective for any reoperation, whereas heterotaxy (HR, 3.43) was a risk factor. For left atrioventricular valve reoperation, toddlers (HR, 0.35), children (HR, 0.25), and trisomy 21 (HR, 0.16) remained protective, whereas left atrioventricular valve anomaly was a risk factor (HR, 2.61). Likewise, for left ventricular outflow tract reoperation, toddlers (HR, 0.24) and children (HR, 0.06) were protective. Mortality after partial and transitional atrioventricular septal defects repair is minimal, yet reoperation for left atrioventricular valve disease and left ventricular outflow tract obstruction remains significant. Patients requiring repair during infancy are at higher risk of reoperation.

Identifiants

pubmed: 31079807
pii: S0022-5223(18)33146-5
doi: 10.1016/j.jtcvs.2018.10.154
pii:
doi:

Types de publication

Journal Article Webcast

Langues

eng

Sous-ensembles de citation

IM

Pagination

1117-1127.e4

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

Carlos M Mery (CM)

Division of Congenital Heart Surgery, Texas Children's Hospital/Baylor College of Medicine, Houston, Tex. Electronic address: cmmery@gmail.com.

Rodrigo Zea-Vera (R)

Division of Congenital Heart Surgery, Texas Children's Hospital/Baylor College of Medicine, Houston, Tex.

Martin A Chacon-Portillo (MA)

Division of Congenital Heart Surgery, Texas Children's Hospital/Baylor College of Medicine, Houston, Tex.

Wei Zhang (W)

Outcomes and Impact Service, Texas Children's Hospital, Houston, Tex.

M Scott Binder (MS)

Eastern Virginia Medical School, Norfolk, Va.

William B Kyle (WB)

Division of Pediatric Cardiology, Texas Children's Hospital/Baylor College of Medicine, Houston, Tex.

Iki Adachi (I)

Division of Congenital Heart Surgery, Texas Children's Hospital/Baylor College of Medicine, Houston, Tex.

Jeffrey S Heinle (JS)

Division of Congenital Heart Surgery, Texas Children's Hospital/Baylor College of Medicine, Houston, Tex.

Charles D Fraser (CD)

Division of Congenital Heart Surgery, Texas Children's Hospital/Baylor College of Medicine, Houston, Tex.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH